Literature DB >> 29724684

The Neural Bases of Interoceptive Encoding and Recall in Healthy Adults and Adults With Depression.

Danielle C DeVille1, Kara L Kerr1, Jason A Avery2, Kaiping Burrows3, Jerzy Bodurka4, Justin S Feinstein5, Sahib S Khalsa5, Martin P Paulus5, W Kyle Simmons6.   

Abstract

BACKGROUND: Theoretical models assert that the brain's interoceptive network links external stimuli with their interoceptive consequences, thereby supporting later recall of these associations to guide the selection of healthy behaviors. If these accounts are correct, previously reported interoceptive abnormalities in major depressive disorder (MDD) should lead to altered recall of associations between external stimuli and their interoceptive (somatic) consequences. To date, the processes underlying interoceptive recall have never been experimentally investigated.
METHODS: We designed and implemented the Interoceptive Encoding and Recall task to compare interoceptive and exteroceptive recall among subjects with MDD (n = 24) and healthy comparison subjects (n = 21). During the encoding phase, subjects learned to pair neutral visual cues (geometric shapes) with aversive interoceptive and exteroceptive stimuli. Later, while undergoing functional magnetic resonance imaging, subjects were prompted to recall the stimulus associated with each shape.
RESULTS: Interoceptive recall, relative to exteroceptive recall, was associated with bilateral mid-to-posterior insula activation. Relative to the healthy control participants, participants with depression exhibited marked hypoactivation of the right dorsal mid-insula during interoceptive recall.
CONCLUSIONS: In healthy control subjects, simply recalling a stimulus associated with a previous interoceptive challenge activated a key region in the brain's interoceptive network. Although previous research has linked MDD with aberrant processing of interoceptive stimuli, the current study is the first to demonstrate that individuals with MDD exhibit decreased insula activity while recalling interoceptive memories. It is possible that insula hypoactivation during interoceptive recall may affect the representation of prior interoceptive experiences in ways that contribute to depressive symptomology and the relationship between depression and systemic health.
Copyright © 2018 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Depression; Insula; Interoception; Learning; Memory; fMRI

Mesh:

Year:  2018        PMID: 29724684      PMCID: PMC6415753          DOI: 10.1016/j.bpsc.2018.03.010

Source DB:  PubMed          Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging        ISSN: 2451-9022


  11 in total

1.  Taking Aim at Interoception's Role in Mental Health.

Authors:  Sahib S Khalsa; Justin S Feinstein; W Kyle Simmons; Martin P Paulus
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2018-06

2.  Neural Correlates of Cardiac Interoceptive Focus Across Development: Implications for Social Symptoms in Autism Spectrum Disorder.

Authors:  Michelle D Failla; Lauren K Bryant; Brynna H Heflin; Lisa E Mash; Kimberly Schauder; Samona Davis; Madison B Gerdes; Amy Weitlauf; Baxter P Rogers; Carissa J Cascio
Journal:  Autism Res       Date:  2020-03-05       Impact factor: 5.216

3.  Impact of serotonergic medication on interoception in major depressive disorder.

Authors:  Kaiping Burrows; Danielle C DeVille; Kelly T Cosgrove; Rayus T Kuplicki; Martin P Paulus; Robin Aupperle; Sahib S Khalsa; Jennifer L Stewart
Journal:  Biol Psychol       Date:  2022-02-08       Impact factor: 3.251

4.  Depression and episodic memory across the adult lifespan: A meta-analytic review.

Authors:  Taylor A James; Samuel Weiss-Cowie; Zachary Hopton; Paul Verhaeghen; Vonetta M Dotson; Audrey Duarte
Journal:  Psychol Bull       Date:  2021-11       Impact factor: 23.027

Review 5.  Interoception and Mental Health: A Roadmap.

Authors:  Sahib S Khalsa; Ralph Adolphs; Oliver G Cameron; Hugo D Critchley; Paul W Davenport; Justin S Feinstein; Jamie D Feusner; Sarah N Garfinkel; Richard D Lane; Wolf E Mehling; Alicia E Meuret; Charles B Nemeroff; Stephen Oppenheimer; Frederike H Petzschner; Olga Pollatos; Jamie L Rhudy; Lawrence P Schramm; W Kyle Simmons; Murray B Stein; Klaas E Stephan; Omer Van den Bergh; Ilse Van Diest; Andreas von Leupoldt; Martin P Paulus
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-12-28

Review 6.  Major Depressive Disorder Is Associated with Impaired Interoceptive Accuracy: A Systematic Review.

Authors:  Michael Eggart; Andreas Lange; Martin J Binser; Silvia Queri; Bruno Müller-Oerlinghausen
Journal:  Brain Sci       Date:  2019-06-06

7.  Perceptual insensitivity to the modulation of interoceptive signals in depression, anxiety, and substance use disorders.

Authors:  Ryan Smith; Justin S Feinstein; Rayus Kuplicki; Katherine L Forthman; Jennifer L Stewart; Martin P Paulus; Sahib S Khalsa
Journal:  Sci Rep       Date:  2021-01-22       Impact factor: 4.996

8.  Item Reduction, Psychometric and Biometric Properties of the Italian Version of the Body Perception Questionnaire-Short Form (BPQ-SF): The BPQ-22.

Authors:  Andrea Poli; Angelo Giovanni Icro Maremmani; Carlo Chiorri; Gian-Paolo Mazzoni; Graziella Orrù; Jacek Kolacz; Stephen W Porges; Ciro Conversano; Angelo Gemignani; Mario Miccoli
Journal:  Int J Environ Res Public Health       Date:  2021-04-06       Impact factor: 3.390

9.  Interoception of breathing and its relationship with anxiety.

Authors:  Olivia K Harrison; Laura Köchli; Stephanie Marino; Roger Luechinger; Franciszek Hennel; Katja Brand; Alexander J Hess; Stefan Frässle; Sandra Iglesias; Fabien Vinckier; Frederike H Petzschner; Samuel J Harrison; Klaas E Stephan
Journal:  Neuron       Date:  2021-10-20       Impact factor: 17.173

10.  Validation of the Multidimensional Assessment of Interoceptive Awareness (MAIA-2) questionnaire in hospitalized patients with major depressive disorder.

Authors:  Michael Eggart; Jennifer Todd; Juan Valdés-Stauber
Journal:  PLoS One       Date:  2021-06-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.